Page 34 - SAMRC Strategic Plan
P. 34

and through disciplines, but also requires great depth   supporting the local development and manufacture
            and rigour in the attendant disciplines. Research also   of medical devices and diagnostics, and the USAID-
            contributes  to  developing  intellectually  engaged   funded  BRILLIANT  programme  which  is  aimed  at
            citizens who can participate meaningfully in their   supporting HIV vaccine development and testing on
            political, social and cultural lives” .            the African continent.
                                          11
            10.4.1.12.  Localisation of Research,              Localisation of research and development (R&D)
                       Development and Innovation              has profound impact on fostering innovation at
            In 2002, the South Africa’s National Research and   scale. Localising R&D efforts can cultivate innovative
            Development  Strategy  stated  that  “adequate     solutions that directly address the health challenges
            responses to new diseases and to old forms of new   confronting South Africans. This commitment entails
            diseases,  whether  these diseases  affect  humans   investing in local talent, forging partnerships with
            or animals, need to be informed by local research   domestic  institutions,  and  conducting  research
            programmes. From a security perspective, even      aligned with the South African context. The 2nd
            being a smart buyer of rapidly developing technology   Presidential Health Compact 2024-2029 mandates
            rather than a developer requires a critical mass of   the academic institutions, the South African Medical
            local scientists doing research in relevant areas. The   Research Council, and the Council for Scientific and
            S&T capacity of the country is running as fast as it   Industrial Research to collaborate and produce a
            can but is still losing ground” .                  joint strategy to fast-track research and development
                                      12
                                                               processes, mainly focusing on the co-development
            In  September  2023,  the  Department  of  Science   of state-owned intellectual property.
            and Innovation (DSI) announced the conclusion
            of  a  financing  agreement  with  Germany's  KfW   10.4.1.13. Indigenous Knowledge Systems
            Development Bank to produce vaccines. Under the    The lack of access to healthcare services, combined
            agreement  the  German  government,  through  KfW,   with the erosion of traditional healing practices,
            will provide South Africa with €20 million for vaccine   contributes to the health disparities experienced
            development  and  production  infrastructure  over   by Black South Africans. Commitment is required to
            a  period  of  five  years.  The  grant  is  exclusively  for   reclaim and revitalise traditional knowledge about
            financing equipment for the development, production   medicinal plants in the country, as well as promote
            and certification of active pharmaceutical ingredients   their safe use for primary healthcare. There is a
            for vaccine production in South Africa. The grant will   growing need to incorporate traditional medicines
            be used, among other things, to support the mRNA   into the broader healthcare system and thus
            Technology Transfer Hub that South Africa is hosting   investment is necessary to make traditional medicines
            for  the  World  Health  Organization  as  well  as  the   more acceptable by establishing quality standards
            South African vaccine manufacturing strategy, led by   as  well  as  confirming  efficacy  and  safety  through
            the DSI. The DSI is the recipient of the KfW financial   laboratory testing. The SAMRC is supporting various
            support on behalf of the South African government   pilot projects to progress traditional medicines to
            and the SAMRC is the project executing agency. The   clinical evaluation as well as platforms to support the
            programme will provide critical support to bolstering   laboratory validation of these medicines.
            vaccine research and development, including pre-
            clinical research, infrastructure and establishing a   10.4.1.14. Exchange rate
            vaccine manufacturing industry in South Africa.    Exchange  rate  volatility  is  often  a  reflection  of
                                                               broader economic instability. This can create
            Further localisation initiatives led by the SAMRC   uncertainty  in  SAMRC's  financial  planning  and
            include the TIA-funded Medical Device and          make it challenging to budget effectively. Overall,
            Diagnostic Innovation Cluster Programme, which is


            11   STI Decadal .jpg (406×572) (dst.gov.za). Accessed 2 September 2024
            12  South Africa's National Research and Development Strategy (www.gov.za) accessed 3 September 2024


                                     SAMRC   STRATEGIC PLAN 2025/26 – 2029/30                             33
   29   30   31   32   33   34   35   36   37   38   39